Connect Biopharma Holdings (CNTB) Shares Outstanding (2020 - 2026)

Connect Biopharma Holdings has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $56.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.16% year-over-year to $56.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.5 million (up 2.16% YoY) and the FY2025 annual result came in at $55.7 million, up 0.81% from the prior year.
• Shares Outstanding (Entity) rose to $56.5 million in Q1 2026 per CNTB's latest filing, from $55.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $56.5 million in Q1 2026 and troughed at $55.0 million in Q4 2022.
• A 5-year average of $55.4 million and a median of $55.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) increased 5.49% in 2022, then decreased 0.02% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $55.0 million in 2022, then increased by 0.04% to $55.1 million in 2023, then increased by 0.27% to $55.2 million in 2024, then grew by 0.81% to $55.7 million in 2025, then gained by 1.59% to $56.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $56.5 million, $55.7 million, and $55.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.